Summary

The global cannabis market size is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms of value. The cannabis market is driven by the rise in the use of cannabis for recreational and medical use. Moreover, there has been an increased legalization of cannabis in the US in states like Virginia in 2021 and Rhode Island in 2022 and in other countries like in Malta in 2021, and Thailand in 2018.
The cannabis industry is growing rapidly and witnessing a double-digit growth rate globally. There are several major companies operating in the cannabis segment that dominate their respective markets. Thus, companies are competing to gain a significant market share. The leading players in the cannabis market and medical industry are undertaking inorganic growth strategies, such as expansions & investments and acquisitions—to increase their profits and market shares. For instance, in May 2020, Aurora Cannabis Inc. completed the acquisition of Reliva LLC (US), a leader in the sales of hemp-derived CBD products in the US. The acquisition took place for USD 40 million of Aurora's common shares. This acquisition would enable the company to strengthen its position in the market and increase profitability.

“By application, the recreational segment is projected to grow at the highest CAGR during the forecast period.”
Recreational cannabis demand is increasing continuously driven by Gen Z consumers. A small but encouraging portion of cannabis products are being sold to women due to a shift in public opinion, and this percentage is predicted to increase over time. Moreover, legalization has have led to a trend toward cannabis-related tourism, with locations producing novel holiday items to entice clients and increasing travel bookings to cannabis-legal destinations.
“By compound, the THC-dominant segment is estimated to account for the largest share.”
THC strain is used for both medical and recreational applications, which increases its demand among manufacturers as well as consumers. Growing Together Research Inc., an Indiana-based biotechnology business, has created a new technique for genetically regulating the expression of Delta-9-THC in cannabis, including the capacity to boost cannabinoid levels in marijuana varieties grown for recreational or medical purposes. Moreover, other forms of THC, such as delta-8-THC, are gaining popularity in addition to the conventional version.
“The Europe region is projected to grow at the highest CAGR during the forecast period”
The market in Europe is majorly driven by the awareness of medical benefits of cannabis in the region coupled with the healthcare system present in several European countries that covers the health expenditure of most patients in these regions. As the legalization of cannabis in European countries is at a nascent stage, this creates a considerable opportunity for companies to establish themselves in the region. Since the beginning of 2019, the European cannabis market has witnessed multiple mergers and acquisitions involving companies focused on medical cannabis. Like in the starting of 2021 medical cannabis firm GW Pharmaceutical was acquired by Jazz Pharmaceutical for USD 6.15 Billion.

Break-up of Primaries:
By Value Chain Side: Demand Side-59%, Supply Side-41%
By Designation: CXOs-31%, Managers – 24%, D-Level- 30%, and Executives- 45%
By Region: Europe - 25%, Asia Pacific – 15%, North America - 45%, RoW – 5%, South America-10%

Leading players profiled in this report:
• Canopy Growth Corporation (Canada)
• Aurora Cannabis Inc. (Canada)
• Medmen Enterprise Inc. (US)
• Tilray Inc. (US)
• Unrivaled Brand Inc. (US)
• VIVO Cannabis Inc. (Canada)
• The Cronos Group (Canada)
• Medical Marijuana Inc. (US)
• Stenocare (Denmark)
• Trulieve (US)
• Organigrams Holding Inc. (Canada)
• Cresco Labs (US)
• Maricann Group Inc. (Canada)
• Indiva (Canada)
• Hexo Corp. (Canada)
• Ecofibre Limited (Australia)
• Curaleaf Holdings Inc. (US)
• Harvest Health and Recreation (US)
• Green Thumb Industries (US)
• TerrAscend (Canada)

Research Coverage:
The report segments the cannabis market on the basis on product type, application, compound, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global cannabis, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.

Reasons to buy this report:
• To get a comprehensive overview of the cannabis market
• To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
• To gain insights about the major countries/regions in which the cannabis market is flourishing

ページTOPに戻る

Table of Contents

1 INTRODUCTION 36
1.1 STUDY OBJECTIVES 36
1.2 MARKET DEFINITION 36
1.3 STUDY SCOPE 37
FIGURE 1 MARKET SEGMENTATION 37
1.3.1 INCLUSIONS AND EXCLUSIONS 37
1.3.2 REGIONS COVERED 38
1.3.3 YEARS CONSIDERED 38
1.4 CURRENCY CONSIDERED 39
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2017–2021 39
1.5 STAKEHOLDERS 39
1.6 SUMMARY OF CHANGES 40
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
FIGURE 2 CANNABIS MARKET: RESEARCH DESIGN 41
2.1.1 SECONDARY DATA 42
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 43
2.1.2.1 Key data from primary sources 43
2.1.2.2 Key industry insights 44
2.1.2.3 Breakdown of primary interviews 44
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS BY COMPANY TYPE, DESIGNATION, AND REGION 44
2.2 MARKET SIZE ESTIMATION 45
FIGURE 4 CANNABIS MARKET SIZE ESTIMATION, BY TYPE (SUPPLY-SIDE) 46
FIGURE 5 CANNABIS MARKET SIZE ESTIMATION (DEMAND-SIDE) 46
2.2.1 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 47
FIGURE 6 CANNABIS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 47
2.2.2 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 47
FIGURE 7 CANNABIS MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 48
2.3 DATA TRIANGULATION 49
FIGURE 8 DATA TRIANGULATION 49
2.4 ASSUMPTIONS 50
2.5 RESEARCH LIMITATIONS AND ASSOCIATED RISKS 51
3 EXECUTIVE SUMMARY 52
TABLE 2 CANNABIS MARKET SHARE SNAPSHOT, 2022 VS. 2027 (USD MILLION) 52
FIGURE 9 CANNABIS MARKET SIZE, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 53
FIGURE 10 CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022 VS. 2027 (USD MILLION) 53
FIGURE 11 CANNABIS MARKET SIZE, BY COMPOUND, 2022 VS. 2027 (USD MILLION) 54
FIGURE 12 CANNABIS MARKET SHARE AND GROWTH RATE (VALUE), BY REGION, 2021 54
4 PREMIUM INSIGHTS 56
4.1 ATTRACTIVE OPPORTUNITIES IN CANNABIS MARKET 56
FIGURE 13 GROWING MEDICINAL APPLICATIONS AND INCREASING LEGALIZATION OF CANNABIS CREATE OPPORTUNITIES IN MARKET 56
4.2 CANNABIS MARKET: MAJOR REGIONAL SUBMARKETS 56
FIGURE 14 NORTH AMERICA ACCOUNTED FOR LARGEST SHARE GLOBALLY IN 2021 56
4.3 NORTH AMERICA: CANNABIS MARKET, BY COMPOUND AND COUNTRY 57
FIGURE 15 IN 2021, US ACCOUNTED FOR LARGEST SHARE IN NORTH AMERICA 57
4.4 CANNABIS MARKET, BY APPLICATION 57
FIGURE 16 RECREATIONAL SEGMENT TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD 57
4.5 CANNABIS MARKET, BY COMPOUND 58
FIGURE 17 TETRAHYDROCANNABINOL (THC)-DOMINANT COMPOUND TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD 58
4.6 CANNABIS MARKET, BY PRODUCT TYPE AND REGION 58
FIGURE 18 NORTH AMERICA TO DOMINATE CANNABIS MARKET DURING FORECAST PERIOD 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MACROECONOMIC INDICATORS 59
5.2.1 INCREASE IN AGING POPULATION 59
FIGURE 19 INCREASING POPULATION OF INDIVIDUALS AGED 60 AND ABOVE (2021–2021) 60
5.2.2 ECONOMIC DOWNTURN 60
FIGURE 20 UNEMPLOYMENT AS A PERCENTAGE OF TOTAL LABOR FORCE (2010–2021) 61
5.3 MARKET DYNAMICS 62
FIGURE 21 CANNABIS MARKET DYNAMICS 62
5.3.1 DRIVERS 62
5.3.1.1 Rising cannabis demand for medicinal applications 62
5.3.1.2 Legalization of cannabis and rise in social acceptance 63
FIGURE 22 GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 2020 64
5.3.1.3 Growth in R&D activities and technological advancements to be precursors for cannabis business 64
5.3.1.4 Rising global cannabis sales helping online retailers expand 66
5.3.2 RESTRAINTS 66
5.3.2.1 Complex regulatory structure for use of cannabis 66
5.3.2.2 Problems associated with high dose of cannabis consumption 67
5.3.2.3 Stigmatization of cannabis market 67
5.3.2.4 Profit margins of manufacturers shrinks as cannabis prices fall 68
FIGURE 23 AVERAGE SELLING PRICES OF CANNABIS, 2019–2022 68
5.3.3 OPPORTUNITIES 69
5.3.3.1 Emergence of cannabis legalization in Asia Pacific 69
5.3.3.2 Edibles, led by gummies and chocolates, to present additional growth opportunities for cannabis business 70
5.3.3.3 Inorganic growth strategies adopted by US cannabis companies 70
5.3.4 CHALLENGES 71
5.3.4.1 Intensive water consumption and inability to maintain consistency during cannabis cultivation 71
5.3.4.2 Cannabis-producing businesses face financing difficulties in US 71
5.3.4.3 Advertising and marketing restrictions in US 72
5.3.4.4 Supply chain challenges associated with cannabis in US 72
6 INDUSTRY TRENDS 73
6.1 INTRODUCTION 73
6.2 VALUE CHAIN 73
6.2.1 RESEARCH AND PRODUCT DEVELOPMENT 73
6.2.2 RAW MATERIAL SOURCING 73
6.2.3 PRODUCTION 74
6.2.4 PACKAGING, STORAGE, AND DISTRIBUTION 74
6.2.5 RETAIL 74
FIGURE 24 CANNABIS MARKET: VALUE CHAIN 75
6.3 SUPPLY CHAIN ANALYSIS 75
FIGURE 25 CANNABIS MARKET: SUPPLY CHAIN 75
6.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
6.4.1 REVENUE SHIFT AND NEW REVENUE POCKETS IN CANNABIS MARKET 76
FIGURE 26 REVENUE SHIFT IMPACTING CANNABIS MARKET 76
6.5 MARKET MAPPING AND ECOSYSTEM OF CANNABIS MARKET 76
6.5.1 DEMAND-SIDE 76
6.5.2 SUPPLY-SIDE 77
FIGURE 27 CANNABIS MARKET ECOSYSTEM MAP 77
6.5.3 ECOSYSTEM MAP 77
TABLE 3 CANNABIS MARKET: ECOSYSTEM 77
6.6 TECHNOLOGY ANALYSIS 79
6.6.1 LED GLOW LIGHT 79
6.6.2 NANOENCAPSULATION 79
6.6.3 ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN 80
FIGURE 28 PROCESSES TRACKED BY USING SEED-TO-SALE TRACKER 81
6.6.4 CROP STEERING 81
6.6.5 VERTICAL FARMING 82
6.6.6 INNOVATIVE HARDWARE TECH DEVICES 82
6.6.7 IOT AUTOMATION 83
6.6.8 GENETIC ENGINEERING 83
6.7 PRICING ANALYSIS 84
6.7.1 SELLING PRICES CHARGED BY KEY PLAYERS IN TERMS OF PRODUCT TYPE 84
FIGURE 29 SELLING PRICES OF KEY PLAYERS FOR CANNABIS PRODUCT TYPE 84
TABLE 4 SELLING PRICE OF KEY PLAYERS FOR PRODUCT TYPE 85
FIGURE 30 AVERAGE SELLING PRICE IN KEY REGIONS, BY PRODUCT TYPE, 2018–2021 (USD/KG) 85
TABLE 5 FLOWER: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG) 86
TABLE 6 CONCENTRATES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG) 86
TABLE 7 EDIBLES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG) 86
TABLE 8 TOPICALS & TINCTURES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG) 86
TABLE 9 OTHER PRODUCT TYPES: AVERAGE SELLING PRICE, BY REGION, 2018–2021 (USD/KG) 87
6.8 CANNABIS MARKET: PATENT ANALYSIS 87
FIGURE 31 NUMBER OF PATENTS GRANTED FOR CANNABIS MARKET, 2011–2021 87
FIGURE 32 TOP PATENT APPLICANTS FOR CANNABIS MARKET, 2019–2022 88
FIGURE 33 REGIONAL ANALYSIS OF PATENTS GRANTED FOR CANNABIS MARKET, 2019–2022 88
6.8.1 LIST OF MAJOR PATENTS 88
TABLE 10 LIST OF A FEW PATENTS IN CANNABIS MARKET, 2019–2022 88
6.9 TRADE ANALYSIS: CANNABIS MARKET 90
6.9.1 EXPORT SCENARIO OF HEMP 90
FIGURE 34 HEMP EXPORT, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 90
TABLE 11 EXPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME) 90
6.9.2 IMPORT SCENARIO OF HEMP 91
FIGURE 35 HEMP IMPORT, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 91
TABLE 12 IMPORT DATA OF HEMP FOR KEY COUNTRIES, 2021 (VALUE AND VOLUME) 91
6.10 CASE STUDIES: CANNABIS MARKET 92
6.10.1 FILTER420: ATTEMPTS TO BUILD BRAND VALUE 92
6.10.2 ONYX AGRONOMICS: PRECISION CANNABIS FACILITY 92
6.11 KEY CONFERENCES AND EVENTS, 2022–2023 93
TABLE 13 KEY CONFERENCES AND EVENTS IN CANNABIS MARKET 93
6.12 TARIFF AND REGULATORY LANDSCAPE 94
6.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 16 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 17 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
6.12.2 REGULATORY FRAMEWORK 96
FIGURE 36 GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL RECREATIONAL CANNABIS, 2022 96
6.12.2.1 North America 97
FIGURE 37 US CANNABIS REGULATORY OVERVIEW, 2022 97
6.12.2.1.1 US 97
6.12.2.1.1.1 Alaska-legalization measure approved in November 2014 97
6.12.2.1.1.2 Arizona-legalization measure approved in November 2020 97
6.12.2.1.1.3 California-legalization measure approved in November 2016 97
6.12.2.1.1.4 Colorado-legalization measure approved in November 2012 98
6.12.2.1.1.5 Connecticut-legalization measure approved in June 2021 98
6.12.2.1.1.6 Guam-legalization measure approved in April 2019 98
6.12.2.1.1.7 Illinois-legalization measure approved in May 2019 98
6.12.2.1.1.8 Maine-legalization measure approved in November 2016 98
6.12.2.1.1.9 Massachusetts-legalization measure approved in November 2016 98
6.12.2.1.1.10 Michigan-legalization measure approved in November 2018 98
6.12.2.1.1.11 Montana-legalization measure approved in January 2021 99
6.12.2.1.1.12 New Jersey-legalization measure approved in November 2020 99
6.12.2.1.1.13 New Mexico- legalization measure approved in April 2021 99
6.12.2.1.1.14 New York-legalization measure approved in March 2021 99
6.12.2.1.1.15 Oregon-legalization measure approved in November 2014 99
6.12.2.1.1.16 Rhode Island-legalization measure approved in May 2022 100
6.12.2.1.1.17 Vermont-legalization measure approved in January 2018 100
6.12.2.1.1.18 Virginia-legalization measure approved in April 2021 100
6.12.2.1.1.19 Washington-legalization measure approved in November 2012 100
6.12.2.1.2 Canada 100
6.12.2.2 Europe 101
6.12.2.2.1 German-legalization measure approved in 2017 101
6.12.2.2.2 Italy-legalization measure approved in 2014 101
6.12.2.2.3 Denmark-legalization measure approved in January 2018 101
6.12.2.2.4 Malta-legalization measure approved in January 2018 101
6.12.2.2.5 Netherlands-legalization measure approved in January 2013 102
6.12.2.2.6 France-legalization measure approved in March 2022 102
6.12.2.2.7 Switzerland 102
6.12.2.2.8 UK 103
6.12.2.2.9 Belgium 103
6.12.2.2.10 Poland 103
6.12.2.2.11 Czech Republic 103
6.12.2.2.12 Spain 103
6.12.2.2.13 Austria 103
6.12.2.2.14 Norway 103
6.12.2.2.15 Finland 104
6.12.2.2.16 Croatia 104
6.12.2.3 South America 104
6.12.2.3.1 Chile-legalization measure approved in 2015 104
6.12.2.3.2 Colombia-legalization measure approved in 2015 104
6.12.2.3.3 Uruguay-legalization measure approved in December 2013 104
6.12.2.4 Rest of the world 104
6.12.2.4.1 Israel-legalization measure approved in December 2018 104
6.12.2.4.2 Australia-legalization measure approved in February 2016 104
6.12.2.4.3 Thailand 105
6.12.2.4.4 South Korea 105
6.12.2.4.5 Malaysia 105
6.12.2.4.6 South Africa 105
6.13 PORTER’S FIVE FORCES ANALYSIS 105
TABLE 18 CANNABIS MARKET: PORTER’S FIVE FORCES ANALYSIS 106
6.13.1 DEGREE OF COMPETITION 106
6.13.2 BARGAINING POWER OF SUPPLIERS 106
6.13.3 BARGAINING POWER OF BUYERS 107
6.13.4 THREAT OF SUBSTITUTES 107
6.13.5 THREAT OF NEW ENTRANTS 107
6.14 KEY STAKEHOLDERS AND BUYING CRITERIA 107
6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 107
FIGURE 38 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS 108
TABLE 19 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP APPLICATIONS (%) 108
6.14.2 BUYING CRITERIA 108
FIGURE 39 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR 109
TABLE 20 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR 109
7 CANNABIS MARKET, BY PRODUCT TYPE 110
7.1 INTRODUCTION 111
FIGURE 40 CANNABIS MARKET SHARE (VALUE), BY PRODUCT TYPE, 2022 VS 2027 111
TABLE 21 CANNABIS MARKET, BY PRODUCT TYPE, 2018–2021 (USD MILLION) 111
TABLE 22 CANNABIS MARKET, BY PRODUCT TYPE, 2022–2027 (USD MILLION) 112
TABLE 23 CANNABIS MARKET, BY PRODUCT TYPE, 2018–2021 (TONS) 112
TABLE 24 CANNABIS MARKET, BY PRODUCT TYPE, 2022–2027 (TONS) 112
7.2 FLOWERS 113
7.2.1 AUTOMATION AND SUSTAINABLE PACKAGING TO BE KEY TRENDS IN PRE-ROLL DOMAIN 113
TABLE 25 FLOWERS: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION) 114
TABLE 26 FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 115
TABLE 27 FLOWERS: CANNABIS MARKET, BY REGION, 2018–2021 (TONS) 115
TABLE 28 FLOWERS: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS) 115
7.3 CONCENTRATES 115
7.3.1 VARIOUS DELIVERY METHODS RESULTED IN CONSUMER-FRIENDLY CANNABIS CONCENTRATES MARKET 115
TABLE 29 CONCENTRATES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION) 117
TABLE 30 CONCENTRATES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION) 117
TABLE 31 CONCENTRATES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS) 118
TABLE 32 CONCENTRATES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS) 118
7.4 EDIBLES 118
7.4.1 FOOD AND BEVERAGE MANUFACTURING COMPANIES VENTURE INTO CANNABIS-INFUSED EDIBLES 118
TABLE 33 EDIBLES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION) 119
TABLE 34 EDIBLES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION) 120
TABLE 35 EDIBLES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS) 120
TABLE 36 EDIBLES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS) 120
7.5 TOPICALS & TINCTURES 120
7.5.1 TOPICALS WITNESS INCREASED DEMAND IN SKINCARE INDUSTRY 120
TABLE 37 TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION) 121
TABLE 38 TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION) 121
TABLE 39 TOPICALS & TINCTURES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS) 122
TABLE 40 TOPICALS & TINCTURES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS) 122
7.6 OTHER PRODUCT TYPES 122
TABLE 41 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION) 123
TABLE 42 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION) 123
TABLE 43 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2018–2021 (TONS) 123
TABLE 44 OTHER PRODUCT TYPES: CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS) 124
8 CANNABIS MARKET, BY COMPOUND 125
8.1 INTRODUCTION 126
FIGURE 41 CANNABIS MARKET SHARE (VALUE), BY COMPOUND, 2022 VS 2027 126
TABLE 45 CANNABIS MARKET, BY COMPOUND, 2018–2021 (USD MILLION) 126
TABLE 46 CANNABIS MARKET, BY COMPOUND, 2022–2027 (USD MILLION) 126
8.2 TETRAHYDROCANNABINOL (THC)-DOMINANT 127
8.2.1 INCREASING LEGALIZATION OF RECREATIONAL CANNABIS PROPELS THC-DOMINANT CANNABIS MARKET 127
TABLE 47 THC-DOMINANT: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION) 128
TABLE 48 THC-DOMINANT: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION) 128
8.3 CANNABIDIOL (CBD)-DOMINANT 128
8.3.1 INCREASED POPULARITY OF CBD EDIBLES TO DRIVE CBD-DOMINANT CANNABIS PRODUCTS MARKET 128
TABLE 49 CBD-DOMINANT: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION) 129
TABLE 50 CBD-DOMINANT: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION) 129
8.4 BALANCED THC & CBD 130
8.4.1 BALANCED THC & CBD STRAINS WITNESS GROWTH AS CBD DIMINISHES PSYCHOACTIVE PROPERTIES OF THC 130
TABLE 51 BALANCED THC & CBD: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION) 130
TABLE 52 BALANCED THC & CBD: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION) 130
9 CANNABIS MARKET, BY APPLICATION 131
9.1 INTRODUCTION 132
FIGURE 42 CANNABIS MARKET SHARE (VALUE), BY APPLICATION, 2022 VS 2027 132
TABLE 53 CANNABIS MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 132
TABLE 54 CANNABIS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 132
9.2 MEDICAL 133
9.2.1 INCREASE IN CANNABIS USE FOR TREATMENT OF VARIOUS AILMENTS DRIVES DEMAND FOR MEDICAL CANNABIS 133
9.2.1.1 Pain management 134
9.2.1.2 Neurological health management 134
9.2.1.3 Mental health management 135
9.2.1.4 Other medical applications 135
TABLE 55 MEDICAL: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION) 137
TABLE 56 MEDICAL: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION) 137
9.3 RECREATIONAL 137
9.3.1 WIDER LEGALIZATION STATUS OF RECREATIONAL CANNABIS TO BOOST MARKET GROWTH 137
TABLE 57 RECREATIONAL: CANNABIS MARKET, BY REGION, 2018–2021 (USD MILLION) 138
TABLE 58 RECREATIONAL: CANNABIS MARKET, BY REGION, 2022–2027 (USD MILLION) 139
10 CANNABIS MARKET, BY REGION 140
10.1 INTRODUCTION 141
FIGURE 43 REGIONAL SNAPSHOT: NEW HOTSPOTS TO EMERGE IN EUROPE, 2022–2027 142
TABLE 59 CANNABIS MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 142
TABLE 60 CANNABIS MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 142
TABLE 61 CANNABIS MARKET SIZE, BY REGION, 2018–2021 (TONS) 143
TABLE 62 CANNABIS MARKET SIZE, BY REGION, 2022–2027 (TONS) 143
10.2 NORTH AMERICA 143
FIGURE 44 NORTH AMERICA: CANNABIS MARKET SNAPSHOT 144
TABLE 63 NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 144
TABLE 64 NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 145
TABLE 65 NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION) 145
TABLE 66 NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION) 145
TABLE 67 NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 145
TABLE 68 NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 146
TABLE 69 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION) 146
TABLE 70 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION) 146
TABLE 71 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS) 147
TABLE 72 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS) 147
10.2.1 US 147
10.2.1.1 Increase in mergers, investments, and sales drive cannabis market in US 147
TABLE 73 US: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 148
TABLE 74 US: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 148
10.2.2 CANADA 148
10.2.2.1 Presence of major players in Canada boosts growth during forecast period 148
TABLE 75 CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 149
TABLE 76 CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 149
10.2.3 MEXICO 149
10.2.3.1 Medical cannabis used for epilepsy treatment boosts Mexican cannabis market growth 149
TABLE 77 MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 150
TABLE 78 MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 150
10.3 EUROPE 151
FIGURE 45 EUROPE: CANNABIS MARKET SNAPSHOT 152
TABLE 79 EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 152
TABLE 80 EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 153
TABLE 81 EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION) 153
TABLE 82 EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION) 153
TABLE 83 EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 153
TABLE 84 EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 154
TABLE 85 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION) 154
TABLE 86 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION) 154
TABLE 87 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS) 154
TABLE 88 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS) 155
10.3.1 GERMANY 155
10.3.1.1 Health insurance coverage for cannabis use in medical treatments driving market 155
TABLE 89 GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 156
TABLE 90 GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 156
10.3.2 ITALY 156
10.3.2.1 Increase in demand for cannabis and issuance of import licenses to drive market 156
TABLE 91 ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 157
TABLE 92 ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 157
10.3.3 DENMARK 157
10.3.3.1 Huge demand for medical cannabis to drive Danish medical cannabis market 157
TABLE 93 DENMARK: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 158
TABLE 94 DENMARK: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 158
10.3.4 NETHERLANDS 158
10.3.4.1 Strong infrastructure and rise in export of medical cannabis to other countries drive market 158
TABLE 95 NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 159
TABLE 96 NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 159
10.3.5 FRANCE 159
10.3.5.1 Government providing finance to healthcare systems and refunds provided to patients 159
TABLE 97 FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 160
TABLE 98 FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 160
10.3.6 REST OF EUROPE 160
TABLE 99 REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 161
TABLE 100 REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 162
10.4 SOUTH AMERICA 162
TABLE 101 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 162
TABLE 102 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 163
TABLE 103 SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION) 163
TABLE 104 SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION) 163
TABLE 105 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 163
TABLE 106 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 164
TABLE 107 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION) 164
TABLE 108 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION) 164
TABLE 109 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS) 165
TABLE 110 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS) 165
10.4.1 CHILE 165
10.4.1.1 Rise in consumption of cannabis for medical usage driving market 165
TABLE 111 CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 166
TABLE 112 CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 166
10.4.2 COLOMBIA 166
10.4.2.1 Increased cannabis license distribution to companies drives market 166
TABLE 113 COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 167
TABLE 114 COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 167
10.4.3 URUGUAY 167
10.4.3.1 Fully legalized cannabis industry with eased regulations drives market 167
TABLE 115 URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 168
TABLE 116 URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 168
10.4.4 REST OF SOUTH AMERICA 168
TABLE 117 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 169
TABLE 118 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 169
10.5 ROW 169
TABLE 119 ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 169
TABLE 120 ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 170
TABLE 121 ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2018–2021 (USD MILLION) 170
TABLE 122 ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2022–2027 (USD MILLION) 170
TABLE 123 ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 170
TABLE 124 ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 171
TABLE 125 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (USD MILLION) 171
TABLE 126 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (USD MILLION) 171
TABLE 127 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018–2021 (TONS) 171
TABLE 128 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2022–2027 (TONS) 172
10.5.1 ISRAEL 172
10.5.1.1 Technical innovations and increased exports to drive market 172
TABLE 129 ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 173
TABLE 130 ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 173
10.5.2 AUSTRALIA 173
10.5.2.1 Surge in epilepsy, chronic pain, and cancer patients resulted in market growth 173
TABLE 131 AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 174
TABLE 132 AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 174
10.5.3 OTHERS IN ROW 174
TABLE 133 OTHERS IN ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2018–2021 (USD MILLION) 175
TABLE 134 OTHERS IN ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2022–2027 (USD MILLION) 175
11 COMPETITIVE LANDSCAPE 176
11.1 OVERVIEW 176
11.2 MARKET SHARE ANALYSIS, 2021 176
TABLE 135 CANNABIS MARKET: DEGREE OF COMPETITION (FRAGMENTED) 177
11.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS 177
FIGURE 46 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN MARKET, 2017–2021 (USD MILLION) 177
11.4 KEY PLAYER STRATEGIES 178
TABLE 136 STRATEGIES ADOPTED BY KEY CANNABIS MANUFACTURERS 178
11.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS) 180
11.5.1 STARS 181
11.5.2 EMERGING LEADERS 181
11.5.3 PERVASIVE PLAYERS 181
11.5.4 PARTICIPANTS 181
FIGURE 47 CANNABIS MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS) 182
11.5.5 PRODUCT FOOTPRINT 182
TABLE 137 COMPANY FOOTPRINT, BY APPLICATION 182
TABLE 138 COMPANY FOOTPRINT, BY TYPE 183
TABLE 139 COMPANY FOOTPRINT, BY REGION 184
TABLE 140 OVERALL COMPANY FOOTPRINT 184
11.6 CANNABIS MARKET: EVALUATION QUADRANT FOR STARTUPS/SMES, 2021 185
11.6.1 PROGRESSIVE COMPANIES 185
11.6.2 STARTING BLOCKS 185
11.6.3 RESPONSIVE COMPANIES 185
11.6.4 DYNAMIC COMPANIES 185
FIGURE 48 CANNABIS MARKET: COMPANY EVALUATION QUADRANT, 2021 (STARTUPS/SMES) 186
11.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 186
TABLE 141 CANNABIS MARKET: DETAILED LIST OF KEY STARTUP/SMES 186
TABLE 142 CANNABIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 187
11.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 188
11.7.1 PRODUCT LAUNCHES 188
TABLE 143 CANNABIS: PRODUCT LAUNCHES, 2019–2022 188
11.7.2 DEALS 189
TABLE 144 CANNABIS: DEALS, 2019–2022 189
11.7.3 OTHERS 191
TABLE 145 CANNABIS: OTHERS, 2019–2022 191
12 COMPANY PROFILES 193
12.1 INTRODUCTION 193
12.2 KEY PLAYER 193
(Business overview, Products/Solutions/Services offered, Recent developments, New product launches, Deals, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats)*
12.2.1 CANOPY GROWTH CORPORATION 193
TABLE 146 CANOPY GROWTH CORPORATION: BUSINESS OVERVIEW 193
FIGURE 49 CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT 194
TABLE 147 CANOPY GROWTH CORPORATION: PRODUCTS OFFERED 194
TABLE 148 CANOPY GROWTH CORPORATION: NEW PRODUCT LAUNCHES 196
TABLE 149 CANOPY GROWTH CORPORATION: DEALS 198
TABLE 150 CANOPY GROWTH CORPORATION: OTHERS 200
12.2.2 CURALEAF 202
TABLE 151 CURALEAF: BUSINESS OVERVIEW 202
FIGURE 50 CURALEAF: COMPANY SNAPSHOT 202
TABLE 152 CURALEAF: PRODUCTS OFFERED 203
TABLE 153 CURALEAF: NEW PRODUCT LAUNCHES 204
TABLE 154 CURALEAF: DEALS 204
TABLE 155 CURALEAF: OTHERS 205
12.2.3 CRESCO LABS 208
TABLE 156 CRESCO LABS: BUSINESS OVERVIEW 208
FIGURE 51 CRESCO LABS: COMPANY SNAPSHOT 208
TABLE 157 CRESCO LABS: PRODUCTS OFFERED 209
TABLE 158 CRESCO LABS: NEW PRODUCT LAUNCHES 210
TABLE 159 CRESCO LABS: DEALS 210
TABLE 160 CRESCO LABS: OTHERS 211
12.2.4 GREEN THUMB INDUSTRIES 214
TABLE 161 GREEN THUMB INDUSTRIES: BUSINESS OVERVIEW 214
FIGURE 52 GREEN THUMB INDUSTRIES: COMPANY SNAPSHOT 214
TABLE 162 GREEN THUMB INDUSTRIES: PRODUCTS OFFERED 215
TABLE 163 GREEN THUMB INDUSTRIES: DEALS 215
TABLE 164 GREEN THUMB INDUSTRIES: OTHERS 216
12.2.5 TILRAY 218
TABLE 165 TILRAY: BUSINESS OVERVIEW 218
FIGURE 53 TILRAY: COMPANY SNAPSHOT 218
TABLE 166 TILRAY INC: PRODUCTS OFFERED 219
TABLE 167 TILRAY: NEW PRODUCT LAUNCHES 219
TABLE 168 TILRAY: DEALS 220
TABLE 169 TILRAY: OTHERS 220
12.2.6 TRULIEVE 222
TABLE 170 TRULIEVE: BUSINESS OVERVIEW 222
FIGURE 54 TRULIEVE: COMPANY SNAPSHOT 222
TABLE 171 TRULIEVE: PRODUCTS OFFERED 223
TABLE 172 TRULIEVE: DEALS 223
TABLE 173 TRULIEVE: OTHERS 224
12.2.7 AURORA CANNABIS INC. 227
TABLE 174 AURORA CANNABIS INC.: BUSINESS OVERVIEW 227
FIGURE 55 AURORA CANNABIS INC.: COMPANY SNAPSHOT 227
TABLE 175 AURORA CANNABIS INC.: PRODUCTS OFFERED 228
TABLE 176 AURORA CANNABIS INC.: NEW PRODUCT LAUNCHES 229
TABLE 177 AURORA CANNABIS INC.: DEALS 230
TABLE 178 AURORA CANNABIS INC.: OTHERS 231
12.2.8 MEDMEN 233
TABLE 179 MEDMEN: BUSINESS OVERVIEW 233
FIGURE 56 MEDMEN: COMPANY SNAPSHOT 233
TABLE 180 MEDMEN: PRODUCTS OFFERED 234
TABLE 181 MEDMEN: OTHERS 234
12.2.9 UNRIVALED BRAND INC. 236
TABLE 182 UNRIVALED BRAND INC.: BUSINESS OVERVIEW 236
FIGURE 57 UNRIVALED BRAND INC.: COMPANY SNAPSHOT 236
TABLE 183 UNRIVALED BRAND INC.: PRODUCTS OFFERED 237
TABLE 184 UNRIVALED BRAND INC.: DEALS 237
TABLE 185 UNRIVALED BRAND INC.: OTHERS 238
12.2.10 ORGANIGRAM HOLDINGS INC. 240
TABLE 186 ORGANIGRAM HOLDINGS INC.: BUSINESS OVERVIEW 240
FIGURE 58 ORGANIGRAM HOLDINGS INC.: COMPANY SNAPSHOT 240
TABLE 187 ORGANIGRAM HOLDINGS INC.: PRODUCTS OFFERED 241
TABLE 188 ORGANIGRAM HOLDINGS INC.: PRODUCT LAUNCH 241
TABLE 189 ORGANIGRAM HOLDINGS INC.: DEALS 242
TABLE 190 ORGANIGRAM HOLDINGS INC.: OTHERS 242
12.2.11 STENOCARE 244
TABLE 191 STENOCARE: BUSINESS OVERVIEW 244
FIGURE 59 STENOCARE: COMPANY SNAPSHOT 244
TABLE 192 STENOCARE: PRODUCTS OFFERED 244
TABLE 193 STENOCARE: DEALS 245
TABLE 194 STENOCARE: OTHERS 245
12.2.12 VIVO CANNABIS INC. 247
TABLE 195 VIVO CANNABIS INC.: BUSINESS OVERVIEW 247
FIGURE 60 VIVO CANNABIS INC.: COMPANY SNAPSHOT 247
TABLE 196 VIVO CANNABIS INC.: PRODUCTS OFFERED 248
TABLE 197 VIVO CANNABIS INC.: NEW PRODUCT LAUNCHES 249
TABLE 198 VIVO CANNABIS INC.: DEALS 250
TABLE 199 VIVO CANNABIS INC.: OTHERS 251
12.2.13 TERRASCEND 252
TABLE 200 TERRASCEND: BUSINESS OVERVIEW 252
FIGURE 61 TERRASCEND: COMPANY SNAPSHOT 252
TABLE 201 TERRASCEND: PRODUCTS OFFERED 253
TABLE 202 TERRASCEND: DEALS 254
TABLE 203 TERRASCEND: OTHERS 255
12.2.14 HEXO CORP 256
TABLE 204 HEXO CORP: BUSINESS OVERVIEW 256
FIGURE 62 HEXO CORP: COMPANY SNAPSHOT 256
TABLE 205 HEXO CORP: PRODUCTS OFFERED 257
TABLE 206 HEXO CORP: NEW PRODUCT LAUNCHES 257
TABLE 207 HEXO CORP: DEALS 258
TABLE 208 HEXO CORP: OTHERS 259
12.2.15 VILLAGE FARMS INTERNATIONAL INC. 260
TABLE 209 VILLAGE FARMS INTERNATIONAL INC.: BUSINESS OVERVIEW 260
FIGURE 63 VILLAGE FARMS INTERNATIONAL INC.: COMPANY SNAPSHOT 261
TABLE 210 VILLAGE FARMS INTERNATIONAL INC.: PRODUCTS OFFERED 261
TABLE 211 VILLAGE FARMS INTERNATIONAL INC.: OTHERS 261
12.2.16 VERANO 263
TABLE 212 VERANO: BUSINESS OVERVIEW 263
FIGURE 64 VERANO: COMPANY SNAPSHOT 263
TABLE 213 VERANO: PRODUCTS OFFERED 263
TABLE 214 VERANO: DEALS 264
TABLE 215 VERANO: OTHERS 266
12.3 OTHER PLAYERS (SMES/STARTUPS) 269
12.3.1 THE CRONOS GROUP 269
TABLE 216 THE CRONOS GROUP: BUSINESS OVERVIEW 269
FIGURE 65 THE CRONOS GROUP: COMPANY SNAPSHOT 269
TABLE 217 THE CRONOS GROUP: PRODUCTS OFFERED 270
TABLE 218 THE CRONOS GROUP: DEALS 271
TABLE 219 THE CRONOS GROUP: OTHERS 272
12.3.2 MEDICAL MARIJUANA, INC. 273
TABLE 220 MEDICAL MARIJUANA, INC.: BUSINESS OVERVIEW 273
FIGURE 66 MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT 273
TABLE 221 MEDICAL MARIJUANA, INC.: PRODUCTS OFFERED 273
TABLE 222 MEDICAL MARIJUANA, INC.: NEW PRODUCT LAUNCHES 274
TABLE 223 MEDICAL MARIJUANA, INC.: DEALS 275
TABLE 224 MEDICAL MARIJUANA, INC.: OTHERS 275
12.3.3 ECOFIBRE LIMITED 277
TABLE 225 ECOFIBRE LIMITED: BUSINESS OVERVIEW 277
FIGURE 67 ECOFIBRE LIMITED: COMPANY SNAPSHOT 277
TABLE 226 ECOFIBRE LIMITED: PRODUCTS OFFERED 278
TABLE 227 ECOFIBRE LIMITED: OTHERS 279
12.3.4 INDIVA 280
TABLE 228 INDIVA: BUSINESS OVERVIEW 280
FIGURE 68 INDIVA: COMPANY SNAPSHOT 280
TABLE 229 INDIVA: PRODUCTS OFFERED 280
TABLE 230 INDIVA: NEW PRODUCT LAUNCHES 281
TABLE 231 INDIVA: DEALS 282
TABLE 232 INDIVA: OTHERS 283
12.3.5 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD. 284
TABLE 233 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: BUSINESS OVERVIEW 284
TABLE 234 TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD.: PRODUCTS OFFERED 284
12.3.6 MARICANN GROUP INC 286
TABLE 235 MARICANN GROUP INC: BUSINESS OVERVIEW 286
TABLE 236 MARICANN GROUP INC: PRODUCTS OFFERED 286
12.3.7 SATIPHARM 288
12.3.8 CANNABLISS ORGANIC LLC 288
12.3.9 CONNECTED CANNABIS CO. 288
12.3.10 JUSTICE CANNABIS CO. 289
12.3.11 HENRY'S ORIGINAL 289
*Details on Business overview, Products/Solutions/Services offered, Recent developments, New product launches, Deals, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 290
13.1 DISCUSSION GUIDE 290
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 295
13.3 CUSTOMIZATIONS OFFERED 297
13.4 RELATED REPORTS 297
13.5 AUTHOR DETAILS 298